Publication | Closed Access

Carrier-free nanoassembly of doxorubicin prodrug and siRNA for combinationally inducing immunogenic cell death and reversing immunosuppression

Cell-based Drug DeliveryNanomedicineEngineeringImmunogenic Cell DeathImmunologyNano-drug DeliveryBiomedical EngineeringImmunotherapyMedicineDoxorubicin Prodrug